We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 348.80
Bid: 349.20
Ask: 350.40
Change: 0.80 (0.23%)
Spread: 1.20 (0.344%)
Open: 350.20
High: 350.20
Low: 348.80
Prev. Close: 348.00
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

5 Jan 2022 17:05

RNS Number : 5617X
QinetiQ Group plc
05 January 2022
 

 

QinetiQ Group plc (the "Company")

On 2 July 2021 the Company announced that Caroline (Carol) Borg, Chief Financial Officer, would receive shares with a value of £500,000 upon her appointment.

 

The Company today announces that on 5 January 2022 Caroline (Carol) Borg was granted 193,199 Ordinary shares of one pence each in the Company (the 'Award') with a value of £500,000.

 

The Award was granted under the terms of the Compensation Share Plan and the Ordinary Shares will vest on the third anniversary of grant subject to continued employment.

 

No consideration was paid for the grant of this award and no payment is due on the release of any shares.

 

The QinetiQ share price used to calculate the number of shares subject to the Award is £2.588 being the average closing price over the 30 day period prior to the award (aligned with the Remuneration Committee's standard approach).

 

The Award is being granted by the Company without prior shareholder approval in general meeting upon reliance of Listing Rule 9.4.2(2) to implement terms agreed to facilitate the participant's recruitment.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities or persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

(a)

Name

Caroline Borg

2.

Reason for the notification

(a)

Position / status

Chief Financial Officer/Director

(b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name

QinetiQ Group plc

(b)

Legal Entity Identifier Code

213800S8OBDOZMCMUW34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

 

Description of the financial instrument

 

Identification code

 

 

 

QinetiQ Group plc ordinary shares of 1 pence

 

 

GB00B0WMWD03

(b)

Nature of the transaction

Award of Shares under the Compensation Share Plan

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

£2.588

193,199

 

(d)

 

Aggregated information

 

- Price

 

- Volume

 

- Total

 

 

 

 

£2.588 per share

 

193,199

 

£499,999.012

 

(e)

Date of the transaction

2022-01-05

(f)

Place of the transaction

Outside of a Trading Venue

 

 

 

Enquiries:

Company Secretary:

Jon Messent, QinetiQ

+44 (0)1252 392000

Investor Relations:

John Haworth, QinetiQ

+44 (0) 7920 545841

Media Relations:

QinetiQ Press Office

+44 (0)1252 393500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSSEFWIEESESF
Date   Source Headline
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20249:32 amRNSHolding(s) in Company
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 202411:55 amRNSResult of Meeting
5th Feb 20243:48 pmRNSDirector/PDMR Shareholding
19th Jan 20249:31 amRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSQ3 Trading Update and Share Buyback Programme
10th Jan 20245:00 pmRNSDirector/PDMR Shareholding
12th Dec 20232:38 pmRNSDirector/PDMR Shareholding
12th Dec 20232:32 pmRNSDirector Declaration
22nd Nov 20238:29 amRNSHolding(s) in Company
20th Nov 20237:00 amRNS$170m US new business contract win
16th Nov 20237:00 amRNSInterim Results
13th Nov 20239:58 amRNSDirector/PDMR Shareholding
25th Oct 20237:23 amRNSInvestor Seminar
17th Oct 20238:00 amRNSDirector Declaration
11th Oct 20237:00 amRNSSecond Quarter Trading Update
10th Oct 20233:56 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNS$127m contract win in the US (formerly Avantus)
3rd Oct 20237:00 amRNS$84m contract win in the US
28th Sep 20233:24 pmRNSDirector/PDMR Shareholding
12th Sep 20235:54 pmRNSDirector/PDMR Shareholding
31st Aug 20235:03 pmRNS$224m contract win in the US (formerly Avantus)
25th Aug 20232:23 pmRNSDirector/PDMR Shareholding
10th Aug 20234:31 pmRNSDirector/PDMR Shareholding
27th Jul 20234:45 pmRNSDirector/PDMR Shareholding
20th Jul 20232:00 pmRNSResult of AGM
20th Jul 20237:00 amRNSFirst Quarter Trading Update
11th Jul 20235:30 pmRNSDirector/PDMR Shareholding
21st Jun 202312:15 pmRNSDirector/PDMR Shareholding
14th Jun 202310:00 amRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector/PDMR Shareholding
12th Jun 20232:00 pmRNSAnnual Financial Report
25th May 20237:00 amRNSResults for the year ended 31 March 2023
10th May 20234:55 pmRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSFourth Quarter Trading Update
12th Apr 202311:35 amRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSQinetiQ announces £259 million renewal of MSCA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.